Triple-negative breast cancer is usually defined as a type of breast cancer that lacks HER2, PR, and ER (Ahmad, 2019; Lee et al., 2019), which has the characteristics of low age of onset, strong invasiveness, poor prognosis, high metastasis rate, recurrence rate, and mortality rate (Won and Spruck, 2020). This evidence concerns the gene ERBB2 and breast carcinoma.